Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT03434353 |
| Consolidated Lead Sponsor | Gilead Sciences |
| Therapeutic Condition Cohort | Infectious Disease and Vaccines |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | TERMINATED |
| Registered Enrollment | 123 participants (ACTUAL) |
| Registered Start Date | 2018-02-28 |
| WhyStopped Classification | Strategic / Business / Sponsor Decision |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Kyungpook National University Hospital | Daegu, South Korea | Open Hospital Dossier -> |
| Severance Hospital, Yonsei University Health System | Seoul, South Korea | Open Hospital Dossier -> |
| Asan Medical Center | Seoul, South Korea | Open Hospital Dossier -> |
| Korea University Guro Hospital | Seoul, South Korea | Open Hospital Dossier -> |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for Gilead Sciences across sibling Meru public-data platforms.
Search related sites and sponsors in the Interactive Directory, explore Infectious Disease and Vaccines Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.